An integrative pan‐cancer analysis of the molecular and biological features of glycosyltransferases
Open Access
- 8 July 2022
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (7) , e872
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (82150111, 91859105, 81961128025)
- Science and Technology Commission of Shanghai Municipality (20JC1418900)
This publication has 10 references indexed in Scilit:
- Global view of human protein glycosylation pathways and functionsNature Reviews Molecular Cell Biology, 2020
- Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinomaNature Communications, 2020
- Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaNature Medicine, 2019
- Integrated Proteogenomic Characterization of HBV-Related Hepatocellular CarcinomaCell, 2019
- A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular CarcinomaCancer Research, 2019
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeCell, 2018
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cellsNature, 2018
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1Cancer Cell, 2018
- A validated gRNA library for CRISPR/Cas9 targeting of the human glycosyltransferase genomeGlycobiology, 2018
- Lunatic, Manic, and Radical Fringe Each Promote T and B Cell DevelopmentThe Journal of Immunology, 2016